Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · Real-Time Price · USD
1.995
+0.035 (1.79%)
Jun 16, 2025, 2:05 PM - Market open
Telomir Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Updated Feb 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.